Randomized trials of PCIs versus CABG surgery: why coronary stenting should remain the first choice of revascularization in non-diabetic patients and why the controversy is still present in diabetics

References

• Bari Investigators. The final 10-years follow-up results from the BARI randomized trial. J Am Coll Cardiol 2007;49(15):1600-6
   PubMed Web of Science ®Google Scholar
• Hamm CW, Reimers J, Ischinger T, et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI). N Engl J Med 1994;331(16):1037-43
   PubMed Web of Science ®Google Scholar
• CABRI Trial Participants. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). Lancet 1995;346(8984):1179-84
   PubMed Web of Science ®Google Scholar
• King SB, Kosinski AS, Guyton RA, et al. Eight-year mortality in the Emory Angioplasty Versus Surgery Trial (EAST). J Am Coll Cardiol 2000;35(5):1116-21
   PubMed Web of Science ®Google Scholar
• Rodriguez AE, Baldi J, Fernández Pereira C, et al. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol 2005;46(4):582-8
   PubMed Web of Science ®Google Scholar
• Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007;115(9):1082-9
   PubMed Web of Science ®Google Scholar
• Serruys PW, Ong AT, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005;46(4):575-81
   PubMed Web of Science ®Google Scholar
• Booth J, Clayton T, Pepper J, et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation 2008;118:381-91
   PubMed Web of Science ®Google Scholar
• Kirtane AJ, Gupta A, Iyengar S, et al. Meta-analysis of randomized trials and observational studies safety and efficacy of drug-eluting and bare metal stents: comprehensive. Circulation 2009;119(25):3198-206
   PubMed Web of Science ®Google Scholar
• Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007;370:937-48
   PubMed Web of Science ®Google Scholar
• Stone GW, Parise H, Witzenbichler B, et al. Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol 2010;56(19):1597-604
   PubMed Web of Science ®Google Scholar
• Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360(10):961-72
   PubMed Web of Science ®Google Scholar
• Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 2011;32(17):2125-34
   PubMed Web of Science ®Google Scholar
• Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013;381(9867):629-38
   PubMed Web of Science ®Google Scholar
• Farkouh ME, Domanski M, Sleeper LA, et al. FREEDOM trial investigators. strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012;367(25):2375-84
   PubMed Web of Science ®Google Scholar
• Dangas GD, Farkouh ME, Sleeper LA, et al. Long term outcome of PCI versus CABG in insulin and non-insulin. J Am Coll Cardiol 2013; In press
   Google Scholar
• Kapur A, Hall RJ, Malik IS, et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol 2010;55(5):432-40
   PubMed Web of Science ®Google Scholar
• Hall R. CARDia: Coronary Artery Revascularisation in Diabetes trial. ESC Congress 2012; Session number 710009-710010
   Google Scholar
• Kamalesh M, Sharp TG, Tang XC, et al. Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes. J Am Coll Cardiol 2013;61:808-16
   PubMed Web of Science ®Google Scholar
• Rodriguez AE. Are drug-eluting stents superior to bare metal stents when compared to coronary artery bypass surgery? Show me the data. Cardiovasc Revasc Med 2013;14(2):90-2
   PubMedGoogle Scholar
• Rodriguez AE, Fernandez-Pereira C, Mieres J. Randomized trials between percutaneous coronary interventions with stents versus coronary artery by pass graft: why we should include complete data from all studies? JAMA; Internal Medicine, In Press, Accepted Manuscript
   Google Scholar
• Daemen J, Boersma E, Flather M, et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 2008;118(11):1146-54
   PubMed Web of Science ®Google Scholar
• Danzi GB, Valenti R, Migliorini A, et al. Percutaneous coronary intervention for multiple chronic total occlusions. Am J Cardiol 2013;112(12):1849-53
   PubMed Web of Science ®Google Scholar
• Valenti R, Migliorini A, Parodi G, et al. Clinical and angiographic outcomes of patients treated with everolimus-eluting stents or first-generation paclitaxel-eluting stents for unprotected left main disease. J Am Coll Cardiol 2012;60(14):1217-22
   PubMed Web of Science ®Google Scholar
• Farooq V, Serruys PW, Zhang Y, et al. Short and long term clinical impact of stent thrombosis and graft occlusion in the synergy between percutaneous coronary intervention with Taxus and cardiac surgery trial: the SYNTAX Trial at 5 years. J Am Coll Cardiol 2013;62(25):2360-9
   PubMed Web of Science ®Google Scholar
• Rodriguez AE, Palacios I, Rodriguez-Granillo AM, et al. Comparison of cost effectiveness of oral rapamycin plus bare metal stents vs. first generation of drug eluting stents (from the randomized Oral Rapamycin in Argentina [ORAR] 3 Trial). Am J Cardiol 2013; doi:10.1016/j.amjcard.2013.11.033
   Google Scholar
• Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009;373(9670):1190-7
   PubMed Web of Science ®Google Scholar
• Flather M, Rhee JW, Boothroyd DB, et al. The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among patients with multivessel coronary disease. A collaborative analysis of individual patient data from 10 randomized trials. J Am Coll Cardiol 2012;60(21):2150-7
   PubMed Web of Science ®Google Scholar
• Garcia S, Sandoval Y, Roukoz H, et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. J Am Coll Cardiol 2013;62(16):1421-31
   PubMed Web of Science ®Google Scholar
• Caixeta A, Leon MB, Lansky AJ, et al. 5-Year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. J Am Coll Cardiol 2009;54(10):894-902
   PubMed Web of Science ®Google Scholar
• Roffi M, Angiolillo DJ, Kappetein AP. Current concepts on coronary revascularization in diabetic patients. Eur Heart J 2011;32(22):2748-57
   PubMed Web of Science ®Google Scholar
• Machecourt J, Danchin N, Lablanche JM, et al. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry. J Am Coll Cardiol 2007;50(6):501-8
   PubMed Web of Science ®Google Scholar
• Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344
   Google Scholar
• Tsuchida K, Colombo A, Lefèvre T, et al. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II). Eur Heart J 2007;28(4):433-42
   PubMed Web of Science ®Google Scholar
• Serruys PW, Onuma Y, Garg S, et al. 5-Year clinical outcomes of the ARTS II(Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol 2010;55(11):1093-101
   PubMed Web of Science ®Google Scholar
• Rodríguez AE, Maree AO, Grinfeld L, et al. Revascularization strategies of coronary multiple vessel disease in drug eluting stent era: one year follow-up results of ERACI III trial. EuroIntervention 2006;2:53-60
   PubMedGoogle Scholar
• Rodríguez AE, Maree AO, Mieres J, et al. Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry. Eur Heart J 2007;28(17):2118-25
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Hlatky M, Grinfeld L, et al. Results in long-term outcome of patients with multiple vessel disease treated with drug eluting, bare metal stents and coronary bypass surgery: insights from five years follow up of ERACI III study. Eur Heart J 2010;31(Suppl 1):1-296
   PubMedGoogle Scholar
• Rodríguez AE, Fernández-Pereira C, Rodríguez-Granillo AM. Changes in the safety paradigm with percutaneous coronary interventions in the modern era: lessons learned from the ASCERT registry. World J Cardiol 2012;4(8):242-9
   PubMedGoogle Scholar
• Nikolsky E, Lansky AJ, Sudhir K, et al. SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease. Am Heart J 2009;158:520-6
   PubMed Web of Science ®Google Scholar
• Stone GW, Midei M, Newman W, et al. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the clinical evaluation of the Xience v everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions (SPIRIT) III trial. Circulation 2009;119:680-6
   PubMed Web of Science ®Google Scholar
• Smits PC, Kedhi E, Royaards K-J, et al. 2-year follow-up of randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice: the COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTE´ stent in all-comers: a randomized open label trial). J Am Coll Cardiol 2011;58:11-18
   PubMed Web of Science ®Google Scholar
• Byrne RA, Kastrati A, Kufner S, et al. Intracoronary stenting and angiographic results: test efficacy of 3 Limus-eluting stents (ISAR-TEST-4) Investigators. Randomized, non-inferiority trial of three Limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial. Eur Heart J 2009;30(20):2441-9
   PubMed Web of Science ®Google Scholar
• Stefanini GG, Byrne RA, Serruys PW, et al. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST3, ISAR-TEST 4, and LEADERS randomized trials. Eur Heart J 2012;33(10):1214-22
   PubMed Web of Science ®Google Scholar
• Sarno G, Lagerqvist B, Fröbert O, et al. Lower risk of stent thrombosis and restenosis with unrestricted use of ‘new-generation’ drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J 2012;33(5):606-13
   PubMed Web of Science ®Google Scholar
• Valgimigli M, Campo G, Monti M, et al. and Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia Study (PRODIGY) Investigators. Short versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial. Circulation 2012;125(16):2015-26
   PubMed Web of Science ®Google Scholar
• Naganuma T, Latib A, Costopoulos C, et al. Evolution of bioresorbable vascular scaffolds and their role in everyday practice. Revista Argentina de Cardioangiología 2013;4(04):0214-19
   Google Scholar
• Otsuka F, Vorpahl M, Nakano M, et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans. Circulation 2014;129(2):211-23
   PubMed Web of Science ®Google Scholar
• Pyxaras SA, Tu S, Barbato E, et al. Co-registration of fractional flow reserve and optical coherence tomography with the use of a three-dimensional angiographic roadmap: an opportunity for optimisation of complex percutaneous coronary interventions. EuroIntervention 2013;9(7):889
   PubMed Web of Science ®Google Scholar
• Ribichini F, Tomai F, Pesarini G, et al. Long-term clinical follow-up of the multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminAte Restenosis (CEREA DES). Eur Heart J 2013;34:1740-8
   PubMed Web of Science ®Google Scholar
• Dasari T, Patel B, Saucedo JF. Systematic review of effectiveness of oral sirolimus after bare-metal stenting of coronary arteries for prevention of in-stent restenosis. Am J Cardiol 2013;112:1322-7
   PubMed Web of Science ®Google Scholar
• Deftereos S, Giannopoulos G, Raisakis K, et al. Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients. J Am Coll Cardiol 2013;61:1679-85
   PubMed Web of Science ®Google Scholar